Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05651334 · ClinicalTrials.gov registry record · Phase 2
Transcranial Magnetic Stimulation in Smokers: an Examination of Mediating Neural Pathways.
A Phase 2 study, sponsored by Kent State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT05651334 is a Phase 2 study that has completed, run by Kent State University. The registered enrollment target is 6 participants.
The verdict
NCT05651334, a Phase 2 study, has completed, sponsored by Kent State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The primary objective of this study is to examine the effects of repetitive transcranial magnetic stimulation (rTMS) on a regulation of craving task (ROC task) and evaluate the feasibility of targeting rTMS via fMRI based neuronavigation. Specifically, we will examine BOLD activation within the DLPFC when control over craving is exerted in order to identify if 1) the task produces reliable activations in an area capable of being targeted by a standard figure-8 coil and 2) examine if the coordinates of the area are distinct from the area targeted via anatomical neuronavigation alone. Last, we will examine if rTMS, compared to sham, is capable of improving cognitive control over craving measured at outcome. The current pilot study will examine these aims in a sample of tobacco dependent adults (N=16) (with final sample size dependent on availability of funds).
Interventions
- DEVICE Sham repetitive Transcranial Magnetic Stimulation
- DEVICE Active repetitive Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-11-08 |
| Est. Completion | 2023-07-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05651334
The ClinicalTrials.gov registry entry for NCT05651334 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kent State University, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham repetitive Transcranial Magnetic Stimulation is the first listed.
NCT05651334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05651334 about?
NCT05651334 is a clinical study titled "Transcranial Magnetic Stimulation in Smokers: an Examination of Mediating Neural Pathways.". The primary objective of this study is to examine the effects of repetitive transcranial magnetic stimulation (rTMS) on a regulation of craving task (ROC task) and evaluate the feasibility of targeting rTMS via fMRI based neuronavigation. Specifically, we will examine BOLD activation within the DLPF...
What is the current status of trial NCT05651334?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2022-11-08. Estimated completion is 2023-07-13.
What interventions are being tested in trial NCT05651334?
The interventions under investigation include: Sham repetitive Transcranial Magnetic Stimulation (DEVICE), Active repetitive Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05651334?
This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.